SCHEMBL3510198

SCHEMBL3510198

COC(=O)c1ccc(Cl)c(Oc2ccccc2C=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
LMNA P02545 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ERN1 O75460 4/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20240279 0.79 LMNA (0.67) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL20240298 0.78 LMNA (0.55) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL29960461 0.78 LMNA (0.55) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL4715538 0.78 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL9271359 0.78 ALDH1A1 (0.57) ALDH1A1LMNAMAPTNPSR1ERN1
SCHEMBL16294809 0.77 LMNA (0.51) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL4504197 0.77 ALDH1A1 (0.49) ALDH1A1LMNAMAPTNPSR1RAB9A
SCHEMBL13574617 0.76 SLC6A3 (0.55) ALDH1A1LMNACYP1A2CYP2C9CYP2C19
SCHEMBL644569 0.75 MAPT (0.63) ALDH1A1LMNAMAPTNPSR1ERN1
SCHEMBL3647722 0.75 ALDH1A1 (0.53) ALDH1A1MAPTERN1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-21 US disclosed
EP-1661879-A1 DIPHENYL ETHER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use PPARG, PPARD, PPARA ALDH1A1 2015/4885LMNA 1343/4885CYP1A2 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.